Goldy Singh

C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ.

Natus Medical, Inc. engages in providing healthcare solutions. It also focuses on the diagnosis and treatment of central nervous and sensory system disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William Jr. New, Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Middleton, WI.

Philips Healthcare is engaged in the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, and patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlands, which is a global company in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions. It classifies its business activities into six areas, namely, Home Healthcare, Professional Healthcare, Imaging Systems, Clinical Care Systems, Healthcare Informatics and Customer Services. The company holds manufacturing facilities in The Netherlands, Germany, the US, Finland, Israel and Brazil. Philips Healthcare is headquartered in Massachusetts, the US.

Part of Becton, Dickinson & Co., Bard Canada, Inc. is a Canadian company that specializes in hospital and surgical specialties. The company is based in Oakville, Canada.

Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.